Tuesday, September 15, 2020

Serum Institute Gets Nod To Resume Oxford COVID-19 Vaccine Trial In India

Drugs Controller General of India Dr VG Somani gave permission to Serum Institute of India to resume clinical trial of the Oxford COVID-19 vaccine candidate in the country.

from NDTV News - Latest https://ift.tt/2Rxkbqa
at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Omara Ventures India Builds Its Designer Jewellery Business Ahead Of Rs 41.99 Crore IPO

The Rs 41.99 crore IPO at the upper price band is scheduled to open on September 30, 2026, and close on October 5, 2026. from NDTV News Se...